Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer

BACKGROUND: Good prognostic tools for predicting disease progression in early stage prostate cancer (PCa) are still missing. Detection of molecular subtypes, for instance by using microarray gene technology, can give new prognostic information which can assist personalized treatment planning. The de...

Descripción completa

Detalles Bibliográficos
Autores principales: Rye, Morten Beck, Bertilsson, Helena, Drabløs, Finn, Angelsen, Anders, Bathen, Tone F, Tessem, May-Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147934/
https://www.ncbi.nlm.nih.gov/pubmed/25115192
http://dx.doi.org/10.1186/1755-8794-7-50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147934/
https://www.ncbi.nlm.nih.gov/pubmed/25115192
http://dx.doi.org/10.1186/1755-8794-7-50

Ejemplares similares